Drug discovery goes au naturel

Clifton E. Barry ()
Additional contact information
Clifton E. Barry: Clifton E. Barry is in the Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-3206, USA.

Nature, 2014, vol. 506, issue 7489, 436-437

Abstract: In a study that showcases the potential of semisynthetic drug design, structural modification of an existing antibiotic with little activity against Mycobacterium tuberculosis has generated a new class of effective antitubercular lead.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/506436a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:506:y:2014:i:7489:d:10.1038_506436a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/506436a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().